info@seagull-health.com
SeagullHealth
语言:
search
new
Indications of Trientine (Curior)
502
Article source: Seagull Pharmacy
Sep 09, 2025

Trientine (Curior) is a copper chelator, with trientine tetrahydrochloride as its main component. It is used for the treatment of adult patients with stable Wilson's disease, and is particularly suitable for patients who have achieved copper depletion and are tolerant to penicillamine.

Indications of Trientine (Curior)

Therapeutic Indications

Wilson's disease: Indicated for adult patients with Wilson's disease who have achieved copper depletion and are tolerant to penicillamine.

Pharmacological action: Through copper chelation, it reduces intestinal absorption of copper and promotes copper excretion.

Target Population & Contraindications

Adult patients: Should be used only after evaluation by a specialist.

Contraindications: Contraindicated in patients with hypersensitivity to trientine or any of its excipients.

Dosage Form, Strength and Characteristics of Trientine (Curior)

Dosage Form and Composition

Dosage form: Film-coated tablets for oral administration.

Strength: Each tablet contains 300 mg of trientine tetrahydrochloride (equivalent to 150 mg of trientine base), and is a functionally scored tablet (can be split into equal parts).

Packaging: The bulk package contains 9 small boxes; each small box contains 8 tablets in aluminum-plastic blister packaging, with a total of 72 tablets.

Appearance: Oval, yellow film-coated tablets, engraved with "OL75" on both sides.

Excipients and Chemical Properties

Inactive ingredients: Colloidal silicon dioxide, glyceryl behenate, mannitol, etc.

Molecular formula: C₆H₂₂N₄Cl₄; Molecular weight: 292.08 g/mol.

Usage and Dosage of Trientine (Curior)

Initial Dosage

The usual initial dosage for adults is 750-1500 mg per day, administered orally in 2 divided doses (morning and evening).

When switching from penicillamine, refer to the dosage conversion table (e.g., 500 mg of penicillamine per day corresponds to 900 mg of CUVRIOR).

Dosage Adjustment

Dosage should be adjusted based on clinical symptoms and serum non-ceruloplasmin copper (NCC) levels. The maximum daily dosage must not exceed 3,000 mg.

If the daily dosage cannot be divided equally, the first dose should be larger than the second (e.g., 1,500 mg per day: 3 tablets in the morning + 2 tablets in the evening).

Administration Precautions

Take on an empty stomach: Administer 1 hour before a meal or 2 hours after a meal. Do not take with food, milk, or other medications.

Mineral supplements: Avoid concurrent use of iron, zinc, calcium, or magnesium preparations. If necessary, iron supplements should be taken with an interval of 2 hours, and other minerals with an interval of 1 hour.

Administration method: Swallow the tablets whole; do not chew or dissolve them. Scored tablets can be split into halves, but blister packs must not be opened in advance for storage.

Note: For internal discussion among medical personnel only. For specific medication, please consult the attending physician. Drug information may change over time. For the latest information, we recommend adding a medical consultant or consulting for free online.
Recommended Articles
How to Use Trientine (CUVRIOR)
Trientine (CUVRIOR) is a copper chelator, with trientine tetrahydrochloride as its main component. It is used for the treatment of adult patients with Wilson's disease who have achieved copper dep...
Precautions for Dacomitinib
It is of great importance for both patients and doctors to understand the precautions before using dacomitinib (Vizimpro). Dacomitinib is an oral targeted therapeutic drug, commonly used in the treatm...
Dacomitinib: Clinical Uses, Recommended Dosage, Potential Side Effects
Dacomitinib is an oral tyrosine kinase inhibitor primarily used as a first-line treatment for patients with metastatic non-small cell lung cancer (NSCLC) harboring specific EGFR gene mutations. EGFR, ...
How to Buy Dacomitinib at a Lower Cost
Dacomitinib, with the English name Dacomitinib, is originally developed by Pfizer Inc. of the United States. It is a highly effective drug for the treatment of metastatic non-small cell lung cancer (N...
What Are the Side Effects of Trientine (Curior)?
Trientine (Cuvrior) is a copper chelator primarily used for the treatment of adult patients with stable Wilson's disease who have achieved copper excretion and are tolerant to penicillamine. Its m...
Indications of ExtraSuperTadarise
ExtraSuperTadarise is a combination preparation mainly used for the treatment of erectile dysfunction (ED) and premature ejaculation (PE) in men.Indications of ExtraSuperTadariseCore IndicationsErecti...
What Kind of Drug Is Dificid (Fidaxomicin)?
Dificid (fidaxomicin) is a macrolide antibacterial drug developed by Merck & Co., Inc. It was approved for marketing by the U.S. FDA in 2011. As a narrow-spectrum antibacterial agent, fidaxomicin ...
Indications of Sirolimus Albumin (Fyarro)
Sirolimus Albumin (Fyarro) is a novel antineoplastic agent specifically indicated for the treatment of adult patients with locally advanced unresectable or metastatic malignant perivascular epithelioi...
Related Articles
Dosage and Administration, Recommended Dosage of Capmatinib (Tabrecta)
Capmatinib (Tabrecta) is a highly selective MET inhibitor, offering a precision treatment option for patients with metastatic non-small cell lung cancer (NSCLC) harboring MET exon 14 skipping mutation...
What Are the Indications for Capmatinib (Tabrecta)?
Capmatinib (Tabrecta) is a targeted therapy medication that plays an important role in the treatment of non-small cell lung cancer associated with specific gene mutations. As a MET kinase inhibitor, i...
What Are the Purchase Channels for Capmatinib (Tabrecta)?
Capmatinib (Tabrecta) is a highly selective MET inhibitor that has demonstrated significant efficacy in patients with metastatic non-small cell lung cancer (NSCLC) harboring MET exon 14 skipping mutat...
Adverse Reactions of Ivosidenib (Tibsovo)
Ivosidenib (Tibsovo) is an isocitrate dehydrogenase 1 (IDH1) inhibitor, primarily indicated for the treatment of patients with acute myeloid leukemia, myelodysplastic syndromes, and cholangiocarcinoma...
What Are the Precautions for Using Ivosidenib (Tibsovo)?
Ivosidenib (Tibsovo) is a targeted therapy medication primarily indicated for the treatment of patients with malignant hematologic diseases harboring specific gene mutations.What Are the Precautions f...
Dosage and Administration, Recommended Dosage of Ivosidenib (Tibsovo)
Ivosidenib (Tibsovo) is a targeted isocitrate dehydrogenase 1 (IDH1) inhibitor that demonstrates significant value in the treatment of malignant tumors with specific gene mutations.Dosage and Administ...
What Are the Indications for Ivosidenib (Tibsovo)?
Ivosidenib (Tibsovo) is an oral isocitrate dehydrogenase-1 (IDH1) inhibitor indicated for patients with various malignant tumors harboring specific IDH1 gene mutations. By inhibiting the activity of m...
What Are the Purchase Channels for Ivosidenib (Tibsovo)?
Ivosidenib (Tibsovo) is an important targeted therapy drug against IDH1 mutations, demonstrating significant efficacy in diseases such as acute myeloid leukemia and cholangiocarcinoma. For patients in...
New Drugs
Infigratinib(Truseltiq)
Infigratinib(Truseltiq)
Treatment of previously treated, unresectable locally advanced or metastatic...
Opicapone(Ongentys)
Opicapone(Ongentys)
Adjunctive treatment to levodopa/carbidopa for reducing "off" episodes in...
Deflazacort(Emflaza)
Deflazacort(Emflaza)
Treatment of Duchenne muscular dystrophy (DMD) in patients aged 2 years and...
Faricimab-svoa(Vabysmo)
Faricimab-svoa(Vabysmo)
Treatment of neovascular age-related macular degeneration, diabetic macular...
Counselling Service
Global Drug Search
Clinical Research Recruitment
Overseas Medical Treatment
Remote Consultations
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Submit
Business
  • Core products
  • Antitumor drugs
  • General drug
  • Antiviral drugs
  • Biological agents
Contact Us 
  • mailbox:info@lucius.la
Welcome to consult
ucius Pharmaceuticals (Lao) Co.,Ltd All rights reserved